Arizona State Retirement System’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105M Sell
484,297
-12,120
-2% -$2.69M 0.62% 21
2025
Q4
$113M Sell
496,417
-19,457
-4% -$4.43M 0.62% 19
2025
Q3
$119M Sell
515,874
-1,274
-0.2% -$259K 0.64% 22
2025
Q2
$96M Sell
517,148
-1,459
-0.3% -$271K 0.55% 24
2025
Q1
$109M Buy
518,607
+5,599
+1% +$1.09M 0.69% 22
2024
Q4
$91.2M Buy
513,008
+6,690
+1% +$1.23M 0.56% 24
2024
Q3
$100M Sell
506,318
-7,003
-1% -$1.31M 0.63% 22
2024
Q2
$88M Buy
513,321
+6,671
+1% +$1.11M 0.59% 22
2024
Q1
$92.3M Buy
506,650
+10,065
+2% +$1.73M 0.64% 22
2023
Q4
$77M Sell
496,585
-2,802
-0.6% -$409K 0.58% 22
2023
Q3
$74.4M Sell
499,387
-4,885
-1% -$717K 0.63% 21
2023
Q2
$67.9M Buy
504,272
+21,402
+4% +$3.14M 0.55% 25
2023
Q1
$77M Buy
482,870
+1,114
+0.2% +$170K 0.69% 19
2022
Q4
$77.9M Buy
481,756
+1,410
+0.3% +$216K 0.75% 20
2022
Q3
$64.5M Sell
480,346
-4,904
-1% -$704K 0.67% 21
2022
Q2
$74.3M Buy
485,250
+145
+0% +$22.2K 0.72% 20
2022
Q1
$78.6M Buy
485,105
+1,110
+0.2% +$161K 0.63% 21
2021
Q4
$65.5M Sell
483,995
-8,537
-2% -$1.01M 0.5% 32
2021
Q3
$53.1M Sell
492,532
-2,225
-0.4% -$254K 0.43% 41
2021
Q2
$55.7M Sell
494,757
-2,761
-0.6% -$311K 0.45% 35
2021
Q1
$53.8M Sell
497,518
-11,690
-2% -$1.25M 0.47% 36
2020
Q4
$54.6M Sell
509,208
-27,930
-5% -$2.68M 0.49% 34
2020
Q3
$47M Buy
537,138
+122,247
+29% +$11.5M 0.47% 38
2020
Q2
$40.7M Buy
414,891
+148,998
+56% +$13.1M 0.57% 31
2020
Q1
$20.3M Sell
265,893
-11,791
-4% -$1M 0.35% 53
2019
Q4
$24.6M Buy
277,684
+1,612
+0.6% +$134K 0.3% 57
2019
Q3
$20.9M Sell
276,072
-5,094
-2% -$349K 0.26% 61
2019
Q2
$20.4M Sell
281,166
-2,076
-0.7% -$163K 0.24% 63
2019
Q1
$22.8M Sell
283,242
-25,821
-8% -$2.11M 0.27% 57
2018
Q4
$28.5M Sell
309,063
-66,256
-18% -$5.83M 0.37% 35
2018
Q3
$35.5M Buy
375,319
+3,020
+0.8% +$286K 0.34% 42
2018
Q2
$34.5M Sell
372,299
-37,787
-9% -$3.69M 0.35% 36
2018
Q1
$38.8M Sell
410,086
-13,300
-3% -$1.46M 0.39% 34
2017
Q4
$40.9M Buy
423,386
+28,210
+7% +$2.66M 0.4% 34
2017
Q3
$35.1M Buy
395,176
+500
+0.1% +$38.1K 0.42% 37
2017
Q2
$28.6M Buy
394,676
+100
+0% +$6.72K 0.4% 44
2017
Q1
$25.7M Sell
394,576
-7,200
-2% -$453K 0.36% 47
2016
Q4
$25.2M Buy
401,776
+700
+0.2% +$42.7K 0.37% 45
2016
Q3
$25.3M Buy
401,076
+4,300
+1% +$278K 0.38% 48
2016
Q2
$24.6M Sell
396,776
-40,100
-9% -$2.44M 0.34% 56
2016
Q1
$25M Sell
436,876
-5,500
-1% -$307K 0.32% 58
2015
Q4
$26.2M Sell
442,376
-10,500
-2% -$605K 0.35% 53
2015
Q3
$24.6M Buy
+452,876
New +$29.5M 0.35% 52
2014
Q4
$43.4M Buy
663,866
+13,400
+2% +$845K 0.51% 33
2014
Q3
$37.6M Sell
650,466
-16,800
-3% -$933K 0.47% 38
2014
Q2
$37.7M Buy
667,266
+11,300
+2% +$593K 0.46% 38
2014
Q1
$33.7M Sell
655,966
-27,000
-4% -$1.36M 0.43% 40
2013
Q4
$36.1M Sell
682,966
-46,828
-6% -$2.3M 0.44% 38
2013
Q3
$32.6M Sell
729,794
-1,600
-0.2% -$70.9K 0.42% 41
2013
Q2
$30.2M Buy
+731,394
New +$32M 0.41% 40

Other funds holding ABBV

Arizona State Retirement System's ABBV Position: Q1 2026 in Review

Arizona State Retirement System reduced its AbbVie (ABBV) stake by 2.4% in Q1 2026, selling an estimated $2.69M and leaving 484,297 shares worth $105M. The position accounts for 0.62% of the portfolio, ranked #21.

Arizona State Retirement System first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $119M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Arizona State Retirement System held 484,297 shares of AbbVie worth $105M as of Q1 2026.
  • Arizona State Retirement System sold 12,120 AbbVie shares in Q1 2026, an estimated $2.69M.
  • AbbVie made up 0.62% of Arizona State Retirement System's portfolio in Q1 2026, its #21 holding.
  • Arizona State Retirement System first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
  • Arizona State Retirement System's AbbVie position peaked at $119M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.